Endotoxin and Sterility Testing: The Analyses a Peptide COA Doesn't Cover
Purity and identity say nothing about bacterial endotoxin or sterility. What the LAL assay measures, why endotoxin survives sterilisation, and when these tests are relevant to in-vitro work.
A peptide Certificate of Analysis addresses two questions: how pure the material is, and what it is. Two questions it does not address are whether the material is sterile, and whether it contains bacterial endotoxin.
These are separate analyses, by different methods, for different reasons — and their absence from a certificate is frequently misread as a pass.
What endotoxin is
Endotoxin is lipopolysaccharide (LPS), a structural component of the outer membrane of Gram-negative bacteria. It is released when those bacteria die and their membranes break down.
The critical property, and the one that makes it a persistent problem: endotoxin is not alive. It is a heat-stable molecule. Consequently:
- Autoclaving does not remove it. Sterilisation kills the bacteria and leaves the LPS behind — arguably making things worse, since lysing the cells releases membrane-bound endotoxin into solution.
- Sterile filtration does not remove it. A 0.22 μm filter retains bacteria. LPS molecules pass straight through.
- A sterile preparation can carry significant endotoxin. The two properties are independent.
Removing endotoxin requires dedicated approaches — depyrogenation by dry heat at high temperature, or affinity-based removal — not the routine sterility measures that are often assumed to cover it.
Why it matters in vitro
Endotoxin is one of the most biologically active contaminants that can enter a cell culture system, and it is active at concentrations that sound negligible.
LPS is the canonical ligand for Toll-like receptor 4 (TLR4). Engagement triggers NF-κB signalling and a downstream inflammatory transcriptional programme. In responsive cell types — macrophages, monocytes, dendritic cells, and endothelial cells to a lesser degree — picogram-per-millilitre quantities produce measurable cytokine responses.
The consequence for a peptide experiment is uncomfortable: endotoxin contamination can produce an apparent effect that has nothing to do with the compound. Add contaminated peptide to a macrophage culture, observe an inflammatory response, and the result is real, reproducible, and about the wrong molecule.
This artefact is hard to detect from the data alone, because it looks like a finding. It is especially awkward in the tissue repair and inflammation literature, where inflammatory readouts are often the endpoint of interest.
How endotoxin is measured
The standard method is the Limulus Amebocyte Lysate (LAL) assay, based on a clotting cascade in the blood of the horseshoe crab that is triggered by endotoxin with remarkable sensitivity. Recombinant Factor C assays now provide an equivalent readout without the animal-derived reagent.
Three common formats:
| Format | Readout | Use |
|---|---|---|
| Gel clot | Clot forms or does not | Simple pass/fail at a threshold |
| Turbidimetric | Rate of turbidity development | Quantitative |
| Chromogenic | Colour development from a synthetic substrate | Quantitative, most widely used |
Results are reported in endotoxin units per milligram (EU/mg) for a solid, or per millilitre for a solution. An EU is defined against a reference standard rather than being a mass unit.
A real endotoxin result therefore states: the method, the format, the result with units, and the specification it was tested against. "Endotoxin: pass" without those is not a result.
Sterility is a different test again
Sterility testing asks whether viable organisms are present, and it is answered by incubation, not by an assay.
The pharmacopoeial approach inoculates the material into growth media supporting bacteria and fungi and incubates for 14 days, looking for growth. Membrane filtration variants concentrate any organisms onto a filter first.
Two things follow. First, sterility testing takes two weeks — it is not something performed incidentally or quickly, and a supplier claiming a sterility result on material dispatched three days after filling has a timeline problem. Second, it is a statistical statement: testing a sample of a batch and finding no growth supports a conclusion about the batch with a confidence that depends on how much was tested.
When these tests are actually relevant
Not always, and it is worth being proportionate.
Lyophilised research peptides are generally not supplied sterile and generally do not carry endotoxin specifications. For biochemical work — binding assays, enzymatic studies, analytical chemistry — this is usually fine. There are no cells to respond.
Cell culture work changes the calculation, particularly with immune-lineage cells or any inflammatory readout. Here endotoxin content is a genuine experimental variable, and if a supplier cannot provide a figure, testing the material yourself is the alternative. Low-endotoxin water and endotoxin-free plasticware are the other half of that problem — the peptide is not the only possible source.
Solvents warrant attention because they go into everything. Bacteriostatic water is a sterile solution, and sterility and endotoxin are the meaningful quality attributes for it — it has no purity figure because there is no peptide in it to assay. See bacteriostatic water.
Reducing contamination at the bench
Endotoxin is ubiquitous — Gram-negative bacteria are everywhere, and their debris persists after they are gone. Practical measures:
- Use endotoxin-free or low-endotoxin water for reconstitution where the work is cell-based.
- Use sterile, endotoxin-free tips and tubes. Ordinary laboratory plastics are not necessarily either.
- Do not store aqueous solutions at room temperature for extended periods; growth produces endotoxin even in solutions that started clean.
- Where an inflammatory readout is the endpoint, run a vehicle control that has been through the identical handling path. It will not identify endotoxin specifically, but it distinguishes a compound effect from a handling effect.
What to ask a supplier
- Is the material supplied sterile? If so, tested how, and to what standard?
- Is there an endotoxin specification? If so, what method, what result, what units?
- Was the specific batch tested, or is this a product-line specification?
For most in-vitro peptide work the honest answer will be that neither test was performed, and that is a legitimate position for a research chemical. The problem is not a supplier who says so — it is a certificate carrying "Sterility: pass" on material that was never incubated for fourteen days. See how to spot a fabricated COA.